SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DI IASIO, Maria Grazia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.337
AS - Asia 1.408
EU - Europa 799
SA - Sud America 268
AF - Africa 24
OC - Oceania 4
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.842
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.291
SG - Singapore 580
CN - Cina 422
BR - Brasile 233
UA - Ucraina 183
DE - Germania 160
GB - Regno Unito 121
HK - Hong Kong 110
TR - Turchia 109
VN - Vietnam 101
IT - Italia 90
FI - Finlandia 61
SE - Svezia 54
RU - Federazione Russa 40
CA - Canada 23
NL - Olanda 17
IN - India 16
MX - Messico 16
AR - Argentina 15
FR - Francia 15
ID - Indonesia 14
PL - Polonia 14
BE - Belgio 13
BD - Bangladesh 11
JP - Giappone 9
ES - Italia 8
ZA - Sudafrica 8
LT - Lituania 7
PY - Paraguay 6
IL - Israele 5
AU - Australia 4
CZ - Repubblica Ceca 4
EC - Ecuador 4
IR - Iran 4
MA - Marocco 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
CL - Cile 3
DZ - Algeria 3
IQ - Iraq 3
JO - Giordania 3
PK - Pakistan 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
HN - Honduras 2
KE - Kenya 2
TT - Trinidad e Tobago 2
AL - Albania 1
AQ - Antartide 1
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
EE - Estonia 1
EG - Egitto 1
GI - Gibilterra 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
MD - Moldavia 1
MN - Mongolia 1
OM - Oman 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.842
Salva come PNG Salva come JPEG
Città #
Fairfield 408
Woodbridge 385
Ashburn 344
Singapore 307
Houston 233
Jacksonville 199
Chandler 169
Beijing 151
Ann Arbor 140
Seattle 137
Santa Clara 128
Wilmington 122
Hong Kong 110
Cambridge 104
Izmir 66
New York 57
Dallas 51
Los Angeles 48
Nanjing 47
Ho Chi Minh City 45
Munich 41
Princeton 40
San Diego 39
Ferrara 32
Boardman 28
São Paulo 23
Hanoi 22
Shanghai 22
Brooklyn 18
Falls Church 18
Nanchang 16
Tianjin 16
Turku 16
Milan 15
Buffalo 14
Mexico City 14
Montreal 14
Changsha 13
Poplar 13
Brussels 12
Hefei 12
London 12
Shenyang 12
Denver 11
Hebei 11
San Mateo 11
Warsaw 11
Dearborn 10
Orem 9
Tokyo 9
Chicago 8
Helsinki 8
Atlanta 7
Columbus 7
Jakarta 7
Jiaxing 7
Norwalk 7
Orange 7
Stockholm 7
Zhengzhou 7
Ankara 6
Boston 6
Chennai 6
Council Bluffs 6
Dronten 6
Jinan 6
The Dalles 6
Verona 6
Washington 6
Auburn Hills 5
Augusta 5
Bremen 5
Johannesburg 5
Kunming 5
Leawood 5
Manchester 5
Mountain View 5
Mumbai 5
Philadelphia 5
Porto Alegre 5
San Francisco 5
Amsterdam 4
Belo Horizonte 4
Bologna 4
Brno 4
Guarulhos 4
Haiphong 4
Phoenix 4
Ribeirão Preto 4
San Jose 4
Tashkent 4
Amman 3
Annapolis 3
Ardabil 3
Falkenstein 3
Frankfurt am Main 3
Goiânia 3
Haikou 3
Hải Dương 3
Monmouth Junction 3
Totale 4.038
Salva come PNG Salva come JPEG
Nome #
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells 221
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 210
Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 193
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 190
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 188
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 184
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 183
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 182
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 175
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 172
Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin 170
HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity 168
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 160
Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms 153
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 153
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 152
Reduced expression of cell cycle-associated genes in B lymphocytes purified from the peripheral blood of early-stage B chronic lymphocytic leukaemia patients 151
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 146
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 144
The non-genotoxic activator of the p53 pathway Nutlin-3 shifts the balance between E2F7 and E2F1 transcription factors in leukemic cells 139
The oncogene DEK promotes leukemic cell survival and is downregulated by both nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells 136
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 136
The MDM2 inhibitor Nutlins as an innovative therapeutic tool for the treatment of haematological malignancies 135
Exposure of B cell chronic lymphocytic leukemia (B-CLL) cells to Nutlin-3 induces a characteristic gene expression profile, which correlates with Nutlin-3-mediated cytotoxicity 131
Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region 130
TNFRSF11B (tumor necrosis factor receptor superfamily, member 11b) 129
SOCS1 is significantly up-regulated in Nutlin-3-treated p53 wild-type B chronic lymphocytic leukemia (BCLL) samples and shows an inverse correlation with miR-155 128
C reactive protein down-regulates TNF-related apoptosis inducing ligand expression in human peripheral monocytes via an Egr-1 dependent pathway. 125
Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women 107
null 100
null 98
null 98
null 97
Risk of venous thromboembolism and stroke associated with oral contraceptives. Role of congenital thrombophilias 94
TNFSF10 (tumor necrosis factor Ligand) surfamily,member 10) 92
null 89
Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype. 89
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. 87
Nutlin-3 downregulates the expression of the Oncogene TCL1 in primary B Chronic Lymphocytic Leukemic cells. 85
null 83
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 81
Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes 71
null 69
null 55
Totale 5.879
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.751
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.751
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021310 0 0 0 0 0 51 18 54 10 59 89 29
2021/2022449 12 60 27 23 22 20 33 22 12 27 52 139
2022/2023398 41 20 20 41 66 57 11 32 54 7 28 21
2023/2024149 23 13 7 3 6 29 8 17 1 4 2 36
2024/2025895 23 21 64 44 122 50 44 38 187 65 135 102
2025/20261.451 259 172 208 314 348 150 0 0 0 0 0 0
Totale 5.879